Related Experiment Videos

Kinetics and dynamics of postoperative intravenous morphine in children

K T Olkkola1, E L Maunuksela, R Korpela

  • 1Department of Clinical Pharmacology, University of Helsinki, Finland.

Insights

Pediatric patients show early pharmacokinetic maturation of intravenous morphine, with distinct profiles in infants under 2.4 months. Analgesic concentrations vary significantly by age group.

Area of Science:

  • Pharmacology
  • Pediatric Medicine
  • Clinical Pharmacy

Background:

  • Intravenous morphine is frequently used for postoperative pain management in children.
  • Understanding pediatric pharmacokinetics is crucial for safe and effective dosing.
  • Maturation of drug metabolism and clearance pathways in neonates and infants is variable.

Purpose of the Study:

  • To determine the pharmacokinetics of intravenous morphine in different pediatric age groups.
  • To correlate morphine pharmacokinetics with respiratory rate, arterial PCO2, and postoperative analgesia.
  • To compare pediatric morphine pharmacokinetics with adult data.

Main Methods:

  • Pharmacokinetic analysis of intravenous morphine in three pediatric groups (0-6 months, 2-4 years, 6 years).
  • Measurement of respiratory rate and arterial PCO2.
  • Assessment of postoperative pain relief.
  • Comparison of pharmacokinetic parameters (clearance, volume of central compartment) across age groups.

Main Results:

  • Children demonstrate early pharmacokinetic maturation, with adult-like parameters by 5-6 months of age.
  • The two youngest infants (11 days and 2.4 months) exhibited significantly lower morphine clearance (5.2 ml/min/kg) and central compartment volume (0.36 L/kg).
  • Mean analgesic morphine concentrations were higher in the youngest group (26.2 µg/L) compared to older children (3.8 µg/L).
  • Morphine's effect on respiration was consistent across all pediatric groups and similar to adults.

Conclusions:

  • Pediatric patients achieve early maturation of morphine pharmacokinetics, with notable differences in neonates and young infants.
  • Age-dependent variations in morphine pharmacokinetics necessitate careful dosing considerations in the youngest pediatric population.
  • Morphine's respiratory effects appear consistent across pediatric age groups, though not analyzed in the youngest.

Related Concept Videos